SE0201937D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- SE0201937D0 SE0201937D0 SE0201937A SE0201937A SE0201937D0 SE 0201937 D0 SE0201937 D0 SE 0201937D0 SE 0201937 A SE0201937 A SE 0201937A SE 0201937 A SE0201937 A SE 0201937A SE 0201937 D0 SE0201937 D0 SE 0201937D0
- Authority
- SE
- Sweden
- Prior art keywords
- group
- aryl
- optionally substituted
- alkyl group
- fluoro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201937A SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Therapeutic agents |
BR0311840-1A BR0311840A (pt) | 2002-06-20 | 2003-06-17 | Composto, formulação farmacêutica, método para tratar ou evitar resistência à insulina, uso de um composto, e, processo para prepará-lo |
CNB038143194A CN100400512C (zh) | 2002-06-20 | 2003-06-17 | 作为PPARα和γ调节剂的苯甲酸衍生物 |
NZ536972A NZ536972A (en) | 2002-06-20 | 2003-06-17 | Benzoic acid derivatives as modulators of ppar alpha and gamma |
EP03732715A EP1517680A1 (en) | 2002-06-20 | 2003-06-17 | Benzoic acid derivatives as modulators of ppar alpha and gamma |
PL03375078A PL375078A1 (en) | 2002-06-20 | 2003-06-17 | Benzoic acid derivatives as modulators of ppar alpha and gamma |
CA002490687A CA2490687A1 (en) | 2002-06-20 | 2003-06-17 | Benzoic acid derivatives as modulators of ppar alpha and gamma |
RU2004135542/04A RU2339613C2 (ru) | 2002-06-20 | 2003-06-17 | ПРОИЗВОДНЫЕ БЕНЗОЙНОЙ КИСЛОТЫ КАК МОДУЛЯТОРЫ PPARα И PPARλ |
TW092116379A TW200403209A (en) | 2002-06-20 | 2003-06-17 | Therapeutic agents |
UA20041210011A UA77527C2 (en) | 2002-06-20 | 2003-06-17 | Benzoic acid derivatives as modulators of ppar alpha and ppar gamma, method of synthesis, pharmaceutical composition, intermediate |
KR10-2004-7020684A KR20050014014A (ko) | 2002-06-20 | 2003-06-17 | Ppar 알파 및 감마의 조절물질로서 벤조산 유도체 |
AU2003240101A AU2003240101B2 (en) | 2002-06-20 | 2003-06-17 | Benzoic acid derivatives as modulators of PPAR alpha and gamma |
PCT/GB2003/002598 WO2004000295A1 (en) | 2002-06-20 | 2003-06-17 | Benzoic acid derivatives as modulators of ppar alpha and gamma |
JP2004515010A JP4327085B2 (ja) | 2002-06-20 | 2003-06-17 | PPARαおよびγのモジュレーターとしての安息香酸誘導体 |
US10/518,819 US7521461B2 (en) | 2002-06-20 | 2003-06-17 | Benzoic acid derivatives as modulators of PPAR alpha and gamma |
MXPA04012694A MXPA04012694A (es) | 2002-06-20 | 2003-06-17 | DERIVADOS DE áCIDO BENZOICO COMO MODULARES DE RECEPTORES ACTIVADOS POR PROLIFERADOR DE PEROXIZOMA ( Y (. |
ARP030102199A AR040332A1 (es) | 2002-06-20 | 2003-06-20 | Derivados de acido benzoico como moduladores de ppar alfa y gamma |
NO20045222A NO20045222L (no) | 2002-06-20 | 2004-11-29 | Benzosyrederivater som modulatorer av PPAR alfa og gamma |
ZA200409690A ZA200409690B (en) | 2002-06-20 | 2004-11-30 | Benzoic acid derivatives as modulators PPAR alpha and gamma. |
IL16567204A IL165672A0 (en) | 2002-06-20 | 2004-12-09 | Benzoic acid derivatives as modulators of prar alpha and gamma |
IS7639A IS7639A (is) | 2002-06-20 | 2005-01-12 | Bensósýruafleiður sem stillar PPAR alfa og gamma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201937A SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0201937D0 true SE0201937D0 (sv) | 2002-06-20 |
Family
ID=20288295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0201937A SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Therapeutic agents |
Country Status (21)
Country | Link |
---|---|
US (1) | US7521461B2 (is) |
EP (1) | EP1517680A1 (is) |
JP (1) | JP4327085B2 (is) |
KR (1) | KR20050014014A (is) |
CN (1) | CN100400512C (is) |
AR (1) | AR040332A1 (is) |
AU (1) | AU2003240101B2 (is) |
BR (1) | BR0311840A (is) |
CA (1) | CA2490687A1 (is) |
IL (1) | IL165672A0 (is) |
IS (1) | IS7639A (is) |
MX (1) | MXPA04012694A (is) |
NO (1) | NO20045222L (is) |
NZ (1) | NZ536972A (is) |
PL (1) | PL375078A1 (is) |
RU (1) | RU2339613C2 (is) |
SE (1) | SE0201937D0 (is) |
TW (1) | TW200403209A (is) |
UA (1) | UA77527C2 (is) |
WO (1) | WO2004000295A1 (is) |
ZA (1) | ZA200409690B (is) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
WO2004000790A1 (en) * | 2002-06-20 | 2003-12-31 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
US7351858B2 (en) | 2002-06-20 | 2008-04-01 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
WO2005026134A1 (en) * | 2003-09-17 | 2005-03-24 | Novartis Ag | Organic compounds |
CN101098690A (zh) * | 2004-12-06 | 2008-01-02 | 瑞莱恩特医药品有限公司 | 用于血脂治疗的ω-3脂肪酸和脂血异常剂 |
KR101478933B1 (ko) * | 2004-12-28 | 2015-01-02 | 키넥스 파마슈티컬즈, 엘엘씨 | 세포 증식 질환의 치료를 위한 조성물 및 방법 |
US7968574B2 (en) | 2004-12-28 | 2011-06-28 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US7816405B2 (en) * | 2005-04-19 | 2010-10-19 | Eisai R&D Management Co., Ltd. | Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof |
JP2009507846A (ja) * | 2005-09-07 | 2009-02-26 | プレキシコン,インコーポレーテッド | Ppar活性化合物 |
JP2007234800A (ja) | 2006-02-28 | 2007-09-13 | Tdk Corp | 電子部品及びその製造方法 |
RU2456265C2 (ru) * | 2006-03-31 | 2012-07-20 | Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем | Биологически доступная для перорального применения кофейная кислота, относящаяся к противоопухолевым лекарственным средствам |
JP5564251B2 (ja) * | 2006-06-29 | 2014-07-30 | キネックス ファーマシューティカルズ, エルエルシー | キナーゼカスケードを調節するためのビアリール組成物および方法 |
US7935697B2 (en) | 2006-12-28 | 2011-05-03 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
EP3053440B1 (en) | 2007-04-11 | 2020-08-12 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
CN102905700A (zh) | 2010-04-16 | 2013-01-30 | 金克斯医药品有限公司 | 用于预防和治疗癌症的组合物以及方法 |
WO2013019621A1 (en) * | 2011-07-29 | 2013-02-07 | Tempero Pharmaceuticals, Inc. | Compounds and methods |
CN109999040A (zh) | 2012-08-30 | 2019-07-12 | 阿西纳斯公司 | 蛋白质酪氨酸激酶调节剂 |
KR102603436B1 (ko) * | 2017-11-30 | 2023-11-16 | 쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드 | 방향족 화합물, 약학적 조성물 및 그 용도 |
JP2023546996A (ja) * | 2020-10-23 | 2023-11-08 | ニンバス クロソー, インコーポレイテッド | Ctps1阻害剤およびその使用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2517229A1 (de) * | 1975-04-18 | 1976-10-28 | Boehringer Mannheim Gmbh | Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung |
DK148576A (da) * | 1975-04-18 | 1976-10-19 | Boehringer Mannheim Gmbh | Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling |
US5334753A (en) * | 1992-03-12 | 1994-08-02 | Rhone-Poulenc Agriculture Ltd | Processes for preparing ortho-substituted benzoic acids |
DE19615263A1 (de) | 1996-04-18 | 1997-10-23 | Bayer Ag | Benzyloxy-substituierte Phenylglycinolamide |
DE19616948C1 (de) | 1996-04-27 | 1997-11-27 | Wagner Gmbh J | Schneidwerkzeug, insbesondere Astschere |
JPH1072371A (ja) | 1996-08-28 | 1998-03-17 | Sankyo Co Ltd | 回腸型胆汁酸トランスポーター阻害剤 |
US5922767A (en) * | 1996-10-30 | 1999-07-13 | Ss Pharmaceutical Co., Ltd. | Substituted benzylurea derivatives and medicine containing the same |
CN1302206A (zh) * | 1997-10-17 | 2001-07-04 | 阿温蒂斯药物制品公司 | 喹啉衍生物的治疗用途 |
NZ503809A (en) | 1997-12-19 | 2002-04-26 | Schering Ag | Ortho-anthranilamide derivatives as anti-coagulants |
SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
DE19825804C2 (de) | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
GB9822473D0 (en) * | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
SK15532001A3 (sk) | 1999-04-28 | 2002-06-04 | Aventis Pharma Deutschland Gmbh | Deriváty kyselín s dvoma arylovými zvyškami ako ligandy receptorov PPAR a farmaceutické kompozície, ktoré ich obsahujú |
PT1177176E (pt) | 1999-04-28 | 2006-08-31 | Aventis Pharma Gmbh | Derivados de acidos triarilicos como ligandos de receptores ppar. |
JP4618845B2 (ja) | 1999-06-09 | 2011-01-26 | 杏林製薬株式会社 | ヒトペルオキシゾーム増殖薬活性化受容体(PPAR)αアゴニストとしての置換フェニルプロピオン酸誘導体 |
GB9919411D0 (en) * | 1999-08-18 | 1999-10-20 | Zeneca Ltd | Chemical compounds |
US6509374B2 (en) * | 2000-04-17 | 2003-01-21 | Novo Nordisk A/S | Compounds, their preparation and use |
SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
-
2002
- 2002-06-20 SE SE0201937A patent/SE0201937D0/xx unknown
-
2003
- 2003-06-17 BR BR0311840-1A patent/BR0311840A/pt not_active IP Right Cessation
- 2003-06-17 KR KR10-2004-7020684A patent/KR20050014014A/ko not_active Application Discontinuation
- 2003-06-17 MX MXPA04012694A patent/MXPA04012694A/es not_active Application Discontinuation
- 2003-06-17 TW TW092116379A patent/TW200403209A/zh unknown
- 2003-06-17 UA UA20041210011A patent/UA77527C2/uk unknown
- 2003-06-17 US US10/518,819 patent/US7521461B2/en not_active Expired - Fee Related
- 2003-06-17 EP EP03732715A patent/EP1517680A1/en not_active Withdrawn
- 2003-06-17 CN CNB038143194A patent/CN100400512C/zh not_active Expired - Fee Related
- 2003-06-17 CA CA002490687A patent/CA2490687A1/en not_active Abandoned
- 2003-06-17 NZ NZ536972A patent/NZ536972A/en unknown
- 2003-06-17 WO PCT/GB2003/002598 patent/WO2004000295A1/en active Application Filing
- 2003-06-17 RU RU2004135542/04A patent/RU2339613C2/ru not_active IP Right Cessation
- 2003-06-17 PL PL03375078A patent/PL375078A1/xx not_active Application Discontinuation
- 2003-06-17 JP JP2004515010A patent/JP4327085B2/ja not_active Expired - Fee Related
- 2003-06-17 AU AU2003240101A patent/AU2003240101B2/en not_active Ceased
- 2003-06-20 AR ARP030102199A patent/AR040332A1/es not_active Application Discontinuation
-
2004
- 2004-11-29 NO NO20045222A patent/NO20045222L/no not_active Application Discontinuation
- 2004-11-30 ZA ZA200409690A patent/ZA200409690B/en unknown
- 2004-12-09 IL IL16567204A patent/IL165672A0/xx unknown
-
2005
- 2005-01-12 IS IS7639A patent/IS7639A/is unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004000295A1 (en) | 2003-12-31 |
CN1662230A (zh) | 2005-08-31 |
AR040332A1 (es) | 2005-03-30 |
EP1517680A1 (en) | 2005-03-30 |
NO20045222L (no) | 2005-01-19 |
PL375078A1 (en) | 2005-11-14 |
TW200403209A (en) | 2004-03-01 |
RU2004135542A (ru) | 2005-08-10 |
ZA200409690B (en) | 2005-10-11 |
MXPA04012694A (es) | 2005-03-23 |
US20050267149A1 (en) | 2005-12-01 |
IL165672A0 (en) | 2006-01-15 |
RU2339613C2 (ru) | 2008-11-27 |
BR0311840A (pt) | 2005-03-15 |
IS7639A (is) | 2005-01-12 |
CA2490687A1 (en) | 2003-12-31 |
JP2006502105A (ja) | 2006-01-19 |
UA77527C2 (en) | 2006-12-15 |
KR20050014014A (ko) | 2005-02-05 |
AU2003240101A1 (en) | 2004-01-06 |
JP4327085B2 (ja) | 2009-09-09 |
AU2003240101B2 (en) | 2006-09-21 |
CN100400512C (zh) | 2008-07-09 |
NZ536972A (en) | 2006-06-30 |
US7521461B2 (en) | 2009-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0201937D0 (sv) | Therapeutic agents | |
BR0309447A (pt) | Composto, agente, processos para a preparação dos mesmos, e para o combate do crescimento de plantas indesejadas, e, uso do composto | |
BR122012009489B8 (pt) | processo para produzir 2-etóxi-1-{[2-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso | |
EA200600527A1 (ru) | Активирующее ppar соединение и содержащая его фармацевтическая композиция | |
EA199700194A1 (ru) | Производные пиразол-4-илбензоила и их применение в качестве гербицидов | |
CA2628131A1 (en) | Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods | |
HUP0004529A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló szulfonilezett dipeptid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk | |
ATE282614T1 (de) | Phenylharnstoff und phenylthioharnstoffderivate | |
AR064414A1 (es) | Derivados de 1-azoniabiciclo[2, 2, 2]octano y 1-azabiciclo[2, 2, 2]oct-3-ilo, un proceso para su preparacion, una composicion farmaceutica que los comprende, procedimiento de obtencion de la misma, su uso en la elaboracion de un medicamento para el tratamiento de epoc y un producto farmaceutico que | |
HRP20040429B1 (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
AR063804A1 (es) | Compuestos de azoniabiciclo[2.2.2]octano | |
RU2009143926A (ru) | Производные пиридина, замещенные гетероциклическим циклом и фосфоноаминогруппой, и содержащее их противогрибковое средство | |
AR035235A1 (es) | Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento | |
PE20070212A1 (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
ATE259376T1 (de) | Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren | |
ATE182889T1 (de) | Bicyclische amidinderivate als no-synthetase inhibitoren | |
ATE525366T1 (de) | Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten | |
ATE276257T1 (de) | Pyrazinonderivate | |
RS51320B (sr) | Derivati imidazohinolina kao veznici a3 receptora adenozina | |
UY28688A1 (es) | Derivados de amida | |
DE60216610D1 (de) | Verwendung von kondensierten Pyrazolverbindungen für die Herstellung eines Arzneimittels zur Behandlung von Bluthochdruck | |
EA200401077A1 (ru) | 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b | |
AR035982A1 (es) | Derivados de c-furano-2-il-metilamina y c-tiofeno-2-il-metilamina sustituidos y metodo de preparacion | |
KR910002818A (ko) | 4,5,6,7-사치환된 벤즈옥사졸론 |